Medtronic (Minneapolis) in mid-June received FDA approval of its Attain StarFix OTW (over-the-wire) lead. The company said it's the first active fixation left-heart lead for cardiac resynchronization therapy (CRT) and that the lead has demonstrated a 0% chronic (meaning more than one day post-implant) dislodgement rate.
Browse by Speciality Area